February 9, 2018

The Trendlines Group Ltd. announced that its subsidiary, Trendlines Medical Singapore Pte. Ltd. will collaborate with Ozi Amanat’s Singapore-based venture capital firm K2 Global Pte Ltd and has been appointed as one of the partners under the Startup SG Equity scheme, administered by SPRING SEEDS Capital Pte. Ltd.. In July 2017, SSC announced a SGD100 million investment allocation to groom start-ups and issued a call to the appointed partners to coinvest in the health and biomedical sciences and other fields. Share price closed at S$0.138